ICCM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Icecure Medical Ltd (ICCM) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, no positive trading signals, and lacks significant catalysts or news to support a strong upward movement. While revenue has increased, the company is still operating at a net loss, and gross margin has declined. Given the user's preference for long-term investments and the lack of immediate positive signals, holding off on buying is recommended.
The stock is currently in a bearish trend. The MACD is below 0 and negatively contracting, RSI indicates the stock is oversold at 15.099, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upside potential in the short term.
Revenue increased by 46.17% YoY in the latest quarter (2025/Q4). EPS improved significantly, up 200% YoY.
Net income dropped by -5.20% YoY, and gross margin declined by -23.88% YoY. No recent news or significant trading trends from hedge funds or insiders. Stock trend analysis indicates a likelihood of minor declines in the short term.
In 2025/Q4, revenue increased to $1,279,000 (up 46.17% YoY). However, net income dropped to -$4,246,000 (down -5.20% YoY), and gross margin fell to 36.28% (down -23.88% YoY). EPS improved to -0.24 (up 200% YoY).
No data available on recent analyst ratings or price target changes.
